|
|
|
|
|
Webinar | Andelyn Biosciences
|
The number of AAV-mediated therapies in clinical trials continues to rise, increasing demand for doses. A scalable platform is crucial to ensure a seamless transfer from pre-clinical to commercial.
|
|
|
|
|
|
Video | Charter Medical
|
Discover how single-use technologies support critical fluid management workflows across bioprocessing, cell and gene therapy, and blood management, enabling efficient handling, storage, and transfer.
|
|
|
|
|
|
Video | MilliporeSigma
|
Traditional viral assays introduce turnaround delays. Learn how a novel method combines the broad detection range of NGS with PCR sensitivity to accelerate testing timelines significantly.
|
|
|
|
|
|
Webinar | Lonza
|
Lengthy analytical development creates timeline risks. Deploying a streamlined AAV transient transfection platform de-risks IND filings while cutting process development complexity.
|
|
|
|
|
|
Webinar | MaxCyte, Inc.
|
Introducing genetic material into cells remains a core bottleneck. See how optimized electroporation techniques advance ion channel studies, disease modeling, and gene therapy research
|
|
|
|
|
|
Video | Life Science Leader
|
On this week's episode of the Business of Biotech, Paul Hastings, Founding CEO and Board Member at Nkarta, an allogeneic cell therapy developer, talks about building off-the-shelf CAR NK cell therapies for autoimmune disease.
|
|
|
| Connect With Cell & Gene: |
|
|
|
|
